Geometry.Net - the online learning center
Home  - Health_Conditions - Fanconi Anemia
e99.com Bookstore
  
Images 
Newsgroups
Page 3     41-60 of 113    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Fanconi Anemia:     more books (28)
  1. Fanconi Anemia: A Paradigmatic Disease for the Understanding of Cancer and Aging (Monographs in Human Genetics) by D. Schindler, H. Hoehn, 2007-05-10
  2. Fanconi anemia: A handbook for families & their physicians by Lynn Frohnmayer, 2000
  3. Fanconi Anemia - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications, 2004-09-28
  4. Fanconi Anemia: Clinical, Cytogenetic and Experimental Aspects
  5. Molecular Mechanisms Of Fanconi Anemia by Shamim I., Ph.D. Ahmad, 2004-11
  6. FANCONI ANEMIA, A HANDBOOK FOR FAMILIES & THEIR PHYSICIANS , SECOND EDITION
  7. Fanconi Anemia: A Handbook for Families and Their Physicians
  8. The interplay of Fanconi anemia proteins in the DNA damage response [An article from: DNA Repair] by X. Wang, A.D. D'Andrea,
  9. Fanconi anemia: An entry from Thomson Gale's <i>Gale Encyclopedia of Cancer, 2nd ed.</i> by Michelle, M.S., J.D. Johnson, 2006
  10. Fanconi Anemia Medical Guide by Qontro Medical Guides, 2008-07-09
  11. Chromosome 9 Gene Introduction: Traf2, Fancg, Tsc1, Fanconi Anemia, Complementation Group C, Ralgds, Steroidogenic Factor 1, Syk, Dnm1, Smarca2
  12. Dedicated to the core: Understanding the Fanconi anemia complex [An article from: DNA Repair] by A.M. Gurtan, A.D. D'Andrea, 2006-09-08
  13. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant [An article from: DNA Repair] by R.S. Tebbs, J.M. Hinz, et all 2005-01-02
  14. The Fanconi anemia pathway limits the severity of mutagenesis [An article from: DNA Repair] by J.M. Hinz, P.B. Nham, et all 2006-08-13

41. Fanconi Anemia - Blood And Marrow Transplantation, Medical School, At The Univer
fanconi anemia and BMT Blood and Marrow Transplantation, Medical School, atthe University of Minnesota.
http://www.med.umn.edu/BMT/disease/Fanconi.html
Return to: Medical School Academic Health Center myAHC U of M Home ...
BMT Home

Fairview-University
BMT Program
MMC 803
420 Delaware St SE
Minneapolis, MN 55455
888.601.0787 (toll-free)
bmt@umn.edu
Home Diseases > Fanconi Anemia
Fanconi Anemia
Fanconi Anemia Comprehensive Care Program The Fanconi Anemia Comprehensive Care Program at Fairview-University Medical Center is the single largest treatment center for patients with Fanconi Anemia (FA) in the United States. The care provided is individually tailored to meet the unique needs of each patient and family. This program uses a team of expert health care providers who specialize in FA, applying leading-edge research developed by University of Minnesota scientists. What is Fanconi Anemia? Fanconi Anemia is a rare, inherited disease which causes bone marrow failure. Those with FA have inherited one FA gene from their father and one from their mother. There are at least eight different genes that cause FA. Approximately 1 in 80 to 600 people carry the gene. Carriers are healthy and do not know that they carry the FA gene. If both parents are carriers, each child they have has a 25 percent chance of being affected by Fanconi Anemia. FA affects boys and girls equally. Patients with Fanconi Anemia may have a number of medical problems. Some of the treatments available through the Fanconi Anemia Comprehensive Care Program are:

42. Fanconi Anemia
fanconi anemia Research Fund Mission To find effective treatments and a cure fanconi anemia A Handbook for Families Their Physicians Gives basic
http://www.reference.com/Dir/Health/Conditions_and_Diseases/A/Anemia/Fanconi_Ane
Dictionary Thesaurus Encyclopedia Web Home Premium: Sign up Login
YOUR AD HERE

Dictionary
... Encyclopedia - Web Directory
Web Directory
Top Health Conditions and Diseases A ... Anemia / Fanconi Anemia
Fanconi Anemia Research Fund
Mission: To find effective treatments and a cure for Fanconi anemia, and to provide education and support services to affected families worldwide.
Fanconi Anaemia
A rare disorder found in children that involves the blood and bone marrow. The symptoms include severe aplastic anemia, hypoplasia of the bone marrow, and patchy discoloration of the skin.
Gives basic information, in plain language, about understanding and coping with a serious disorder known as Fanconi anemia, or Fanconi's anemia (FA).

Help build the largest human-edited directory on the web. Submit a Site Open Directory Project Become an Editor
Lexico Publishing Group, LLC
... Contact Us

43. Fanconi Anemia
fanconi anemia is an inherited blood disorder that causes a decreased number ofred blood cells, white
http://my.webmd.com/hw/health_guide_atoz/tv7893.asp
var guid_source = ""; var guid_source_id = ""; //unused var encodedurl = ""; WebMD Today Home
WebMD News Center

XML
News via RSS Member Services
WebMD University

My WebMD

Find a Physician
Medical Info
Check Symptoms

Medical Library

Health Tools

Clinical Trials
... Women, Men, Lifestyle
Who We Are About WebMD Site Map You are in Medical Library Our Content Sources Ask A Question Clinical Trials Health Guide A-Z Health Topics Symptoms Medical Tests Medications ... Support Organizations Fanconi anemia Fanconi anemia is an inherited blood disorder that causes a decreased number of red blood cells, white blood cells, and platelets (pancytopenia), birth defects, and an increased risk for cancer. The disease may also cause problems with the heart or kidneys and abnormalities of the arms and legs. Children and adults with Fanconi anemia usually have short stature, and other growth measurements may also be below normal. Other common problems include bleeding episodes and easy bruising, hormonal problems, and infertility. Fanconi anemia is usually diagnosed during childhood, and many children with this disease do not survive beyond young adulthood.

44. Fanconi Anemia - Information And Support Resources
fanconi anemia Overview, Screening and Testing Information, Support Resources.
http://www.mazornet.com/genetics/fanconi_anemia.asp
Jewish Genetic Diseases
A Mazornet Guide VISIT MazorNet's other Jewish Guides The MazorNet-Jewish Celebrations Kosher Restaurant Guide The MazorNet- Jewish Celebrations Vendor Directory ( ... Photographers, Kosher Caterers, Bridal Gowns, and Much More) Important
Information
Home Page Genetic Counseling and Screening Genetic Screening Laboratories - A Directory A Brief Key to Basic Genetic ... s Select Disorder Bloom's Syndrome Breast and Ovarian Cancers Breast Cancers - Prevention and Resources Canavan Disease ... Ulcerative Colitis Recommended
Reeading
Genetic Diversity Among Jews - Diseases and Markers at the DNA Level
Provides an authoritative, up-to-date account of the impact of molecular genetics on our understanding of genetic diseases prevalent among Jews. Jewish Genetic Disorders : A Layman's Guide
Guide to genetic disorders that tend to affect the Jewish population more than the non-Jewish, including a short history of the Jews and basic facts concerning genetics and genetic disorders. Interactive Jewish Genetic Diseases Boards
Fanconi Anemia Fanconi anemia is an inherited condition characterized by reduced production of all types of blood cells in the body. It is called a “chromosome breakage” condition. This means that people with Fanconi anemia have an unusually high number of breaks along their chromosomes.

45. GeneReviews: Fanconi Anemia
Your browser does not support HTML frames so you must view fanconi anemia in aslightly less readable form. Please follow this link to do so.
http://www.genetests.org/query?dz=fa

46. IBMFS - Fanconi's Anemia (FA, Or Fanconi Anemia)
DiamondBlackfan Anemia Dyskeratosis Congenita; Fanconi s Anemia; Pearson sSyndrome Severe Congenital Neutropenia Shwachman-Diamond Syndrome
http://marrowfailure.cancer.gov/FA.html
What are the IBMFS disorders?
Fanconi's Anemia (FA, or Fanconi Anemia)
FA patients have relatively specific physical findings in ~75% of affected persons. Laboratory findings include aplastic anemia , increased chromosome breakage in cells grown in the presence of a chemical which damages DNA mutation in one of the 8 separate genes which have been completely identified ("cloned"), or assignment to one of the 11 or more sub-categories into which patients with FA can be classified (known as "complementation groups"). Bone marrow failure is NOT required for the diagnosis, and ~25% of all persons eventually diagnosed as being affected by FA do not have the typical FA findings on physical examination. FA has been diagnosed at ages ranging from birth to >50 years of age. Males and females are affected equally.
  • What are the major findings on physical examination?
  • 47. GTX70299-FANCD2 (Fanconi Anemia D2) Antibody [103]-GeneTex Inc.
    FANCD2 (fanconi anemia D2) antibody 103 GTX70299 GTX70299 70299 GTX70299 humanFANCD2 fanconi anemia D2 Clone 103 FANCD2 fanconi anemia D2 103 103 FANCD2
    http://www.genetex.com/ccp7246-fancd2-28fanconi-anemia-d229-antibody-5b1035d-gtx
    Advanced Search Welcome to GeneTex! Product Type Primary Antibodies Secondary Antibodies Ab Combo Pack Cell/Tissue Lysates ... Serum Products Other links Browse Research Areas Browse by Catalog Number Browse by A-Z List About Us ... Join Our Mailing List
    Catalog
    Product Name Cat No Package Price FANCD2 (Fanconi anemia D2) antibody [103] Order Info Qty Add to Product Info Product Name
    Product Description:
    Mouse Monoclonal to human FANCD2 ( Fanconi anemia D2 ) Antibody [Clone 103]
    GeneTex GTX70299
    Background:
    Fanconi Anemia Complementation Group D2 (FANCD2) protein is one of at least six factors shown to be involved in the autosomal-recessive cancer-prone disorder, Fanconi Anemia (FA). FA group D has been shown to be comprised of two separate proteins, FANCD1 and FANCD2. Mutations in BRCA2 can cause FANCD1. FANCD2 has been shown to colocalize with BRCA1 in ionizing radiation-induced foci. FANCD2 is involved in genomic resistance to DNA cross-linking reagents, and the arrest of DNA synthesis following exposure to ionizing radiation. FANCD2 has been shown to directly interact with NBS1
    Purity:
    Protein G affinity purified.

    48. All Fanconi's Anemia
    All products relating to Fanconi s Anemia. FACE, FAE, fanconi anemiacomplementation group E, fanconi anemia group E protei Reacts with Human.
    http://www.abcam.com/?c=880

    49. Kprones FA10001
    Karyotype evolution in the bone marrow of a patient with fanconi anemia Hematologic abnormalities in fanconi anemia an International fanconi anemia
    http://www.infobiogen.fr/services/chromcancer/Kprones/FA10001.html
    Atlas of Genetics and Cytogenetics in Oncology and Haematology
    Home Genes Leukemias Solid Tumours ... NA
    Fanconi anaemia
    Identity Note Fanconi anaemia is a chromosome instability syndrome with progressive bone marrow failure and an increased risk of cancers Other names Fanconi pancytopenia Inheritance autosomal recessive; frequency is about 2.5/10 newborns Clinics Phenotype and clinics
  • growth retardation (70% of cases)
  • skin abnormalities: hyperpigmentation and/or café au lait spots in 80%
  • squeletal malformations (60%), particularly radius axis defects (absent or hypoplastic thumb or radius...)
  • no immune deficiency (in contrast with most other chromosome instability syndromes)
  • progressive bone marrow failure; mean age of onset of anemia: 8 yrs; diagnosis made before onset of haematologic manifestations in only 30%
  • other: renal anomalies, hypogonadism, mental impairment, heart defects, and perhaps diabetes mellitus, also occur in 10 to 30% of cases Neoplastic risk
  • myelodysplasia (MDS) and acute non lyphocytic leukaemia (ANLL): 15% of cases; i.e. a 15000 fold increased risk of MDS and ANLL has been evaluated in FA, and it has been assumed that 'it is reasonable to regard the Fanconi anemia genotype as "preleukemia"'; mean age at diagnosis: 13-15 yrs
  • hepatocarcinoma (androgen-therapy induced) in 10%; mean age at diagnosis: 16 yrs
  • 50. Center For Jewish Genetic Diseases - Department Of Human Genetics - Mount Sinai
    The majority of individuals with fanconi anemia are diagnosed during childhood, Although five subtypes of fanconi anemia exist, it is only Type C that
    http://www.mssm.edu/jewish_genetics/diseases/fanconi_anemia.shtml
    Diseases: Fanconi Anemia anconi anemia is a blood disorder characterized by pancytopenia (deficiency of red blood cells, white blood cells and platelets), increased risk for cancer, and congenital birth defects. The disease is highly variable and is frequently associated with cardiac, kidney and limb abnormalities. Short stature is commonly observed in children and adults with Fanconi anemia, and other growth measurements may also be below normal. Bleeding episodes and bruising are common, as are hormonal problems and infertility. The majority of individuals with Fanconi anemia are diagnosed during childhood, but many do not survive beyond young adulthood. This is frequently a result of leukemia or other cancers, which are due to bone marrow failure. Treatment for Fanconi anemia is primarily preventive. Individuals with Fanconi anemia may pursue bone marrow transplantation on an experimental basis, however there is to date no consistently effective treatment. In order to detect cancers early, individuals with Fanconi anemia should arrange for frequent screenings. In addition, avoidance of sun exposure and other agents which may damage the chromosomes is imperative. Although five subtypes of Fanconi Anemia exist, it is only Type C that occurs with increased frequency among individuals with Ashkenazi Jewish ancestry. It is estimated that approximately 1 in 89 Ashkenazi Jewish individuals are carriers of Type C. All types of Fanconi anemia are inherited in an

    51. Fanconi Anemia - The Doctors Lounge(TM)
    fanconi anemia. Hematology. Medical disease review for USMLE, MRCP. A quicksummary before the exams.
    http://www.thedoctorslounge.net/hematology/diseases/fanconi.htm
    Advertisement
    Powered by

    Careerbuilder
    Search for: Home Humor Advertising Contact ...
    Links

    Other Specialties
    Cardiology

    Chest diseases

    Dermatology

    Endocrinology
    ...
    Urology

    Other Sections Membership Research Tools Medical Tutorials Medical Software ... Specialized Centers Headlines:
    Fanconi anemia
    Clinical suspicion
    Fanconi anemia may occur in any nationality and ethnic group, but one particular gene change is responsible for approximately 83% of cases of Fanconi anemia in Jews of Eastern European descent (Ashkenazi Jews). This allows Ashkenazi Jews to be easily tested for Fanconi anemia. Approximately one in 89 Ashkenazi Jews is a carrier of Fanconi anemia. Fanconi Anemia usually reveals itself when children are between the ages of 3-12 years present with extreme fatigue, and frequent infections or recurrent nosebleeds and bruising. Lab tests reveal normocytic anemia with neutropenia. Short stature, microcephaly, hypogenitalism, strabismus, anomalies of the thumbs, radii, and kidneys, mental retardation, and microphthalmia may all be associated with the disease.
    Are you a physician or a nurse?

    52. Fanconi Anemia
    fanconi anemia links to national and international support groups, clinics withgenetic counselors and geneticists.
    http://www.kumc.edu/gec/support/fanconi.html
    Fanconi Anemia
    Fanconi Anemia Research Fund, Inc. and Support Group
    1801 Willamette Street, Ste. 200, Eugene, OR 97401 Phone: 800-828-4891 (family support) or 541-687-4658 Fax: 541-687-0548 E-mail: info@fanconi.org Web site: www.fanconi.org
    What Is Fanconi Anemia And How Is It Diagnosed?
    Canadian Fanconi Anemia Research Fund (Fanconi Canada)
    P.O Box 38157, Castlewood Postal Outlet, Toronto, ON M5N 3A9
    Telephone: 416.489.6393
    Fax: 416.489.6393
    E-mail: admin@fanconicanada.org
    Website: www.fanconicanada.org
    Canadian Fanconi Anemia Research Fund / La Fondation Canadienne de Recherche de L'Anemie de Fanconi
    European Fanconi Anemia (EUFAR) Center Amsterdam , consortium of nine research groups in France, Germany, Italy, United Kingdom, and the Netherlands.
    De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
    Phone: +31 20 - 444 2420
    Fax: +31 20 - 444 2422
    E-mail: fanconi.org@VUmc.nl
    www.fanconi-anaemia.co.uk
    Also See:
    To locate a genetic counselor or clinical geneticist:

    53. Fanconi Anemia, Complementation Group D2
    You are at Home » Proteins » fanconi anemia, complementation group D2 Suggest aProtein Molecule Authority. fanconi anemia, complementation group D2
    http://www.hprd.org/protein/01968
    You are at: Home Proteins Fanconi anemia, complementation group D2
    Fanconi anemia, complementation group D2 Cell cycle control protein Regulation of cell cycle Signal transduction Cell communication ALTERNATE NAMES ... EXTERNAL LINKS Gene Symbol : Molecular Weight (Da) : Gene Map Locus Localization Primary Nucleus Alternative Domains and Motifs Domains Motifs EXPRESSION Site of Expression Heart Brain Placenta Lung ... Intestine Please send any questions or comments about the Human Protein Reference Database to help
    This is a joint project between: and

    54. Fanconi Anemia
    Published on the Web by the Leukaemia Research Fund. Available in Word format.Patient Education Handout Publication Type; fanconi anemia;
    http://omni.ac.uk/browse/mesh/D005199.html
    low graphics
    Fanconi Anemia
    Fanconi's anaemia A fact sheet, directed at patients, about Fanconi's anaemia (an inherited form of aplastic anaemia in which the bone marrow fails to produce blood cells normally). The fact sheet provides key information such as the causes, signs and symptoms, diagnosis, treatment, and prognosis of Fanconi's anaemia. Published on the Web by the Leukaemia Research Fund. Available in Word format. Patient Education Handout [Publication Type] Fanconi Anemia
    Last modified: 02 Sep 2005

    55. Fanconi Anemia - Diseases And Conditions - Blood And Marrow Transplant
    The fanconi anemia Comprehensive Care Program at FairviewUniversity MedicalCenter is the single largest treatment center for patients with fanconi anemia
    http://www.fairviewbmt.org/Diseases_and_Conditions/c_098205.asp
    var g_HttpRelativeWebRoot = "/fv/"; var SSContributor = false;
    BLOOD/MARROW TRANSPLANT HOME
    FAIRVIEW.ORG HOME
    Inside Blood and Marrow Transplant
    Fairview-University Blood and Marrow Transplant Services 500 Harvard St. Minneapolis, MN 55455 (Street Address) 420 Delaware St. SE MMC 803 Minneapolis, MN 55455 (Mailing Address) BMT Clinic Phillips-Wangensteen Building Clinic 5B, 5-100 516 Delaware St. SE Minneapolis, MN 55455
    Fanconi Anemia
    Jordan's Story
    Historical Milestones Fanconi Anemia Comprehensive Care Program The Fanconi Anemia Comprehensive Care Program at University of Minnesota Medical Center, Fairview is the single largest treatment center for patients with Fanconi Anemia (FA) in the United States.  The care provided is individually tailored to meet the unique needs of each patient and family. This program uses a team of expert health care providers who specialize in FA, applying leading-edge research developed by University of Minnesota scientists.  What is Fanconi Anemia? Fanconi Anemia is a rare, inherited disease which causes bone marrow failure. Those with FA have inherited one FA gene from their father and one from their mother. There are at least eight different genes that cause FA. Approximately 1 in 80 to 600 people carry the gene. Carriers are healthy and do not know that they carry the FA gene. If both parents are carriers, each child they have has a 25 percent chance of being affected by Fanconi Anemia. FA affects boys and girls equally.

    56. Chicago Center For Jewish Genetics Disorders - Ashkenazi Disorders: Fanconi Anem
    fanconi anemia is a disorder characterized by a reduced production of all Testing detects 95% of carriers for this specific type of fanconi anemia.
    http://www.jewishgeneticscenter.org/what/ashkenazi/fanconi.asp
    Ashkenazi Disorders: Mendelian
    Fanconi Anemia Fanconi anemia is a disorder characterized by a reduced production of all types of blood cells in the body. The most serious problem associated with this disorder is an increased risk for cancer. The underlying problem in this condition affects how the genetic information is copied in the cells of the body. The disorder can be seen in individuals from any ethnic background, but one specific gene alteration has been noted in individuals of Jewish ancestry. No effective treatment exists at this time. Disease frequency: Unknown Carrier frequency: Approximately 1 in 89 for a specific gene alteration noted in those of Jewish ancestry. Diagnosis: By a specialized type of chromosome testing or specific testing of one of the genes involved in Fanconi anemia. Inheritance: Autosomal Recessive Carrier testing: Available by testing for a specific gene alteration. Testing detects 95% of carriers for this specific type of Fanconi anemia. Prenatal diagnosis: Available through genetic testing in couples with a previous affected child or couples identified as being carriers. Technical Information on Fanconi Anemia Additional Information:
    Fanconi Anaemia UK
    http://www.fanconi-anaemia.co.uk

    57. Aplastic & Fanconi Anemia / Guidelines, Journal Articles And Books / Updates And
    Home Updates and Resources Guidelines, Journal Articles and Books Aplastic fanconi anemia.
    http://www.anemiainstitute.org/updates_and_resources/guidelines_journal_articles
    Advanced search keyword search About Us Events Advocacy Updates and Resources ... email to a friend
    Clinical Guidelines Screening for hemoglobinopathies in Canada. Canadian Task Force on Preventive Health Care
    link

    Guidelines for red blood cell and plasma transfusion for adults and children: report of the Expert Working Group (also available in French) Canadian Medical Association ( link Guidelines for transfusion of erythrocytes to neonates and premature infants. Canadian Medication Association (available CMAJ 1992; 147:1781-6) Intravenous immunoglobulin preparations. University Health System Consortium. 1999. 216 pages.( link Practice parameter for the use of red blood cell transufsions. College of American Pathologists. 1998. 8 pages. Journal Articles * Aplastic Anemia Taher A, Ammash Z, Dabajah B, Nasrallah A, Mourad FH. Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review. Am J Hematol 2000 Feb;63(2):90-3 Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 1999 Nov;24(9):995-1003 Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajeweski JL, Territo M, Ramsay N, Harris RE et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999;5(4):243-52

    58. Niall Howlett: Fanconi Anemia
    fanconi anemia (FA) is a rare autosomal and Xlinked recessive disorder. The birthincidence of FA is estimated to be approximately 1 in 350000.
    http://www.sitemaker.umich.edu/nhowlett/fanconi_anemia
    Niall Howlett Home Fanconi anemia Fanconi anemia laboratories Fanconi anemia web resources Publications Limerick ... sftp site Fanconi anemia (FA) is a rare autosomal and X-linked recessive disorder. The birth incidence of FA is estimated to be approximately 1 in 350,000. FA is characterized by developmental defects, hematological deficiencies and increased susceptibility to cancer. At the cellular level, FA is defined by heightened sensitivity to DNA interstrand cross-linking agents such as mitomycin C and cisplatin. Contact Information: Niall Howlett
    E-mail: Niallg@UMich.edu
    Phone: 734-763-6169
    Fax: 734-763-3784 UM.SiteMaker Home Configure this Site Upload/Manage Files for this Site

    59. Niall Howlett: Fanconi Anemia Web Resources
    The following is a list of fanconi anemia web resources for families and researchers.The fanconi anemia Research Fund OMIM, fanconi anemia
    http://www.sitemaker.umich.edu/nhowlett/fanconi_anemia_web_resources
    Niall Howlett Home Fanconi anemia Fanconi anemia laboratories Fanconi anemia web resources Publications Limerick Rugby sftp site The following is a list of Fanconi anemia web resources for families and researchers. The Fanconi Anemia Research Fund Hope for Henry Fanconi Anemia Antibody Project OMIM, Fanconi Anemia ... MazorNet Fanconi Anemia Please email me at niallg@umich.edu to have your FA web resource added to this list. Contact Information: Niall Howlett
    E-mail: Niallg@UMich.edu
    Phone: 734-763-6169
    Fax: 734-763-3784 UM.SiteMaker Home Configure this Site Upload/Manage Files for this Site

    60. Arch Otolaryngol Head Neck Surg -- Fanconi Anemia: Adult Head And Neck Cancer An
    fanconi anemia (FA) is an autosomal recessive DNA repair disorder with a veryhigh risk of cancer.12 While most of the homozygotes are identified
    http://archotol.ama-assn.org/cgi/content/extract/131/7/635
    Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress
    Vol. 131 No. 7, July 2005 Featured Link E-mail Alerts Clinical Note Article Options Full text PDF Send to a Friend Related articles in this issue ... Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Alter BP Pals G Articles that cite this article Contact me when this article is cited Topic Collections Oncology Topic Collection Alerts
    Fanconi Anemia Adult Head and Neck Cancer and Hematopoietic Mosaicism Blanche P. Alter, MD, MPH Hans Joenje, PhD Anneke B. Oostra Gerard Pals, PhD
    Arch Otolaryngol Head Neck Surg. Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. INTRODUCTION
    Fanconi anemia (FA) is an autosomal recessive DNA repair disorder with a very high risk of cancer.

    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

    Page 3     41-60 of 113    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

    free hit counter